DK137310B - Fremgangsmade til fremstilling af fedtsyretriglyceridindkapslede legemidler med forsinkel afgivelse af virksomt stof i tarmen - Google Patents

Fremgangsmade til fremstilling af fedtsyretriglyceridindkapslede legemidler med forsinkel afgivelse af virksomt stof i tarmen

Info

Publication number
DK137310B
DK137310B DK303974AA DK303974A DK137310B DK 137310 B DK137310 B DK 137310B DK 303974A A DK303974A A DK 303974AA DK 303974 A DK303974 A DK 303974A DK 137310 B DK137310 B DK 137310B
Authority
DK
Denmark
Prior art keywords
riglyceride
encapped
intestine
medicines
procedure
Prior art date
Application number
DK303974AA
Other languages
English (en)
Other versions
DK137310C (da
DK303974A (da
Inventor
P Speiser
Original Assignee
Schlueter Edelfett
Iberica G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schlueter Edelfett, Iberica G filed Critical Schlueter Edelfett
Publication of DK303974A publication Critical patent/DK303974A/da
Publication of DK137310B publication Critical patent/DK137310B/da
Application granted granted Critical
Publication of DK137310C publication Critical patent/DK137310C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK303974A 1973-12-06 1974-06-06 Fremgangsmaade til fremstilling af fedtsyretriglyceridindkapslede laegemidler med forsinket afgivelse af virksomt stof i tarmen DK137310C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732360796 DE2360796B2 (de) 1973-12-06 1973-12-06 Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm

Publications (3)

Publication Number Publication Date
DK303974A DK303974A (da) 1975-07-28
DK137310B true DK137310B (da) 1978-02-20
DK137310C DK137310C (da) 1978-07-24

Family

ID=5900064

Family Applications (1)

Application Number Title Priority Date Filing Date
DK303974A DK137310C (da) 1973-12-06 1974-06-06 Fremgangsmaade til fremstilling af fedtsyretriglyceridindkapslede laegemidler med forsinket afgivelse af virksomt stof i tarmen

Country Status (11)

Country Link
US (1) US4013784A (da)
JP (1) JPS5089521A (da)
AR (1) AR204629A1 (da)
BE (1) BE811175A (da)
DE (1) DE2360796B2 (da)
DK (1) DK137310C (da)
ES (1) ES423856A1 (da)
FR (1) FR2253508B1 (da)
GB (1) GB1427677A (da)
NL (1) NL7407233A (da)
SE (1) SE7407537L (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
US5112619A (en) * 1985-11-12 1992-05-12 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulation
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
EP0345628B1 (en) * 1988-06-07 1993-05-12 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US6066337A (en) * 1994-01-27 2000-05-23 The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc. Method for producing a rapidly dissolving dosage form
US6207199B1 (en) 1994-01-27 2001-03-27 The Board Of Regents Of The University Of Oklahoma Process for making a particulate support matrix for making a rapidly dissolving dosage form
US6177104B1 (en) 1994-01-27 2001-01-23 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving dosage form
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US6187337B1 (en) 1994-01-27 2001-02-13 The Board Of Regents Of The University Of Oklahoma Rapidly dissolving dosage form
US5635210A (en) * 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10300325A1 (de) * 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
US6992772B2 (en) * 2003-06-19 2006-01-31 Optix Lp Method and apparatus for optical sampling to reduce interfering variances
WO2005000237A2 (en) * 2003-06-25 2005-01-06 University Of Tennessee Research Foundation Granules containing biologically active substances
US20070082029A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
US20070082027A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for reducing food intake and controlling weight
DE102013106998A1 (de) * 2013-07-03 2015-01-08 Thyssenkrupp Industrial Solutions Ag Verfahren sowie eine Vorrichtung zur Herstellung einer Tablette
US10647045B1 (en) * 2016-11-03 2020-05-12 Specialty Earth Sciences, Llc Shaped or sized encapsulated reactant and method of making

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US3629393A (en) * 1969-09-11 1971-12-21 Nikken Chemicals Co Ltd Release-sustaining-tablet

Also Published As

Publication number Publication date
FR2253508B1 (da) 1977-11-10
DE2360796A1 (de) 1975-06-12
ES423856A1 (es) 1976-05-01
GB1427677A (en) 1976-03-10
DK137310C (da) 1978-07-24
JPS5089521A (da) 1975-07-18
DE2360796B2 (de) 1977-06-02
SE7407537L (da) 1975-06-09
AR204629A1 (es) 1976-02-20
US4013784A (en) 1977-03-22
DK303974A (da) 1975-07-28
BE811175A (fr) 1974-06-17
NL7407233A (nl) 1975-06-10
FR2253508A1 (da) 1975-07-04

Similar Documents

Publication Publication Date Title
DK137310B (da) Fremgangsmade til fremstilling af fedtsyretriglyceridindkapslede legemidler med forsinkel afgivelse af virksomt stof i tarmen
NO142155C (no) Fremgangsmaate til fremstilling av orale legemiddelpreparater
DK135563C (da) Fremgangsmade til fremstilling af flydende eller halvfaste emulsionsformige legemidler til topisk applikation
DK155085C (da) (s)-1-aryloxy-2-propanolderivater til anvendelse ved fremstilling af terapeutisk aktive (s)-1-aryloxy-3-amino-2-propanolderivater
AR209752A1 (es) Procedimiento de preparacion de derivados de acido 7-acilamido-3-cefem-4-carboxilico
NO140496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
SE382560B (sv) Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring
SE407935B (sv) Forfarande for framstellning av nya 8-aryl-9-oxo-alkansyror och vissa hogre homologer derav med anvendning som lekemedel
SE420919B (sv) Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
SE418085B (sv) Forfarande for framstellning av nya sulfamoylbensoesyraamider
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
DK132273C (da) Fremgangsmade til fremstilling af trans-chrysanthemsyre
NO144344C (no) Fremgangsmaate for fremstilling av terapeutisk aktive n-arylsulfonyl n`-(3-azabicykloalkyl)urinstoffer
SE406768B (sv) Sett att framstella nya farmaceutiskt verksamma steroider
DK139524B (da) Fremgangsmaade til fremstilling af poly-alfahydroxy-acrylsyre
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat
SE416131B (sv) Forfarande for framstellning av blandade salter av polysvavelsyraestrar av naturligt forekommande glykoptider med metaller och organiska baser
DK133297C (da) Analogifremgangsmade til fremstilling af 6-halogen-6-cyklohexylindan-1-karbohydroxamsyre
DK138316C (da) Analogifremgangsmaade til fremstilling af estere af (beta-(4-hydroxy-thymoxy)ethyl)dimethylamin eller syreadditionssalte deraf
DK138693C (da) Fremgangsmaade til fremstilling af 0,0-dialkyl-0-(2,2-dichlorvinyl)-thionphosphorsyreestere
DK132941C (da) Fremgangsmade til fremstilling af 5-cykloalkyl-6-halogen-indan-1-karboxylsyrederivater
FI48594C (fi) Menetelmä fysiologisesti vaikuttavan metyyli-1-naftyyliditiokarbamiini happo-2-bentsoksatsolyyliesterin valmistamiseksi.
DK135236C (da) Fremgangsmade til fremstilling af polyesterfilamenter med ringe tilbojelighed til pilling
DK132120C (da) Fremgangsmade til fremstilling af dialkyltindithioglykolsyreestere
TR17602A (tr) O-halojenoalkilfosforik asid ester amidler,bunlarin hazirlanmasina mahsus usuller,ve bunlarin ensektisidler ve akarisidler olarak kullanilmalari